Showing results (2641-2650 of 11,730) with videos related to
Sort By:
Pageof 1,173
European Heart Journal|August 1, 1987
Doppler imaging of regurgitant jet in aortic insufficiency: experimental validation and preliminary clinical evaluationB Diebold, R Touati, A Delouche, et al.European Heart Journal|August 1, 1987
Value, sensitivity and specificity of stroke volume ratio in routine equilibrium gated scintigraphyP Gobert, R Krémer, P Rigo, et al.European Heart Journal|June 16, 2018
Heart failure with preserved ejection fraction: from mechanisms to therapiesCarolyn S P Lam, Adriaan A Voors, Rudolf A de Boer, et al.European Heart Journal|February 12, 2015
Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV--a survey from the European Society of CardiologyViveca Gyberg, Dirk De Bacquer, Kornelia Kotseva, et al.European Heart Journal|June 1, 1989
Comparison of the effects of intravenous and oral betaxolol on antegrade and retrograde conduction in patients with atrioventricular nodal reentrant and atrioventricular reentrant tachycardiaV Kühlkamp, O Ickrath, R Haasis, et al.European Heart Journal|February 20, 2015
Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and ManagementErik S Stroes, Paul D Thompson, Alberto Corsini, et al.European Heart Journal|February 19, 2015
Outdoor temperature, blood pressure, and cardiovascular disease mortality among 23 000 individuals with diagnosed cardiovascular diseases from ChinaLing Yang, Liming Li, Sarah Lewington, et al.European Heart Journal|February 4, 2015
Master of Science in cardiovascular health economics launched by European Society of Cardiology and London School of EconomicsJennifer TaylorEuropean Heart Journal|October 3, 2012
Does EuroSCORE II perform better than its original versions? A multicentre validation studyFabio Barili, Davide Pacini, Antonio Capo, et al.European Heart Journal|February 18, 2015
Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trialChristopher P Cannon, Bertrand Cariou, Dirk Blom, et al.Pageof 1,173